Biocryst Pharmaceuticals (BCRX) Return on Sales Growth (5y) (2015 - 2026)

Biocryst Pharmaceuticals (BCRX) Return on Sales Growth (5y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Biocryst Pharmaceuticals 2.02 Bn 1.78 Bn 151.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.00
Dec 31, 2025 362.00
Sep 30, 2025 8.00
Jun 30, 2025 14.00
Mar 31, 2025 8.00
Dec 31, 2024 0.00
Sep 30, 2024 21.00
Jun 30, 2024 26.00
Mar 31, 2024 5.00
Dec 31, 2023 9.00
Sep 30, 2023 20.00
Jun 30, 2023 1.00
Mar 31, 2023 5.00
Dec 31, 2022 4.00
Sep 30, 2022 1.00
Jun 30, 2022 5.00
Mar 31, 2022 0.00
Dec 31, 2021 1.00
Sep 30, 2021 0.00
Jun 30, 2021 2.00